세계의 피임약 시장 : 유형별, 투여 경로별, 연령층별, 유통 채널별, 지역별.

Global contraceptive market was valued US$ 19.74 Bn in 2023 and is expected to reach US$ 52.41 Bn by 2031 exhibiting a compound annual growth rate (CAGR) of 13% from 2024 to 2031.

Figure 1. Global Contraceptive Market Share (%), By Region, 2024

Global contraceptive pill market has been witnessing steady growth over the past few decades. Contraceptive pills, commonly known as birth control pills, contain synthetic versions of the female sex hormones - estrogen and progesterone. They are taken orally to prevent pregnancy by inhibiting ovulation and altering cervical mucus and the lining of the uterus. Changing attitudes towards family planning, rising concern about unplanned pregnancies, growing sexual health awareness, and stricter regulatory norms regarding contraceptive options have boosted the demand for contraceptive pills globally. Moreover, increasing women workforce participation and delayed pregnancies have further augmented the acceptance of oral contraceptive drugs.

Market Dynamics:

Rising female literacy and empowerment are the primary drivers propelling the contraceptive pill market forward. Growing awareness about women's reproductive health and rights has led to a widespread acceptance of contraceptives to delay or plan pregnancies. Rapid urbanization, changing lifestyles, and easier access to modern healthcare are encouraging more women to opt for oral contraceptives. At the same time, the emergence of new products with improved efficacy and fewer side effects as well as innovations to address unmet medical needs in contraception are creating lucrative growth opportunities for market players. However, the presence of alternative family planning methods and contraceptive devices along with some side effects that are associated with hormonal pills such as blood clots, depression, and weight changes are hindering the market growth. Moreover, social stigma and religious reservations in some regions continue to restrain the demand for contraceptive pills.

Key Features of the Study:

• This report provides an in-depth analysis of the global contraceptive market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key market players
• It profiles key players in the global contraceptive market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries, Merck & Co., Janssen Pharmaceutical Companies, Allergan, Piramal Enterprises, Glenmark Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Mithra Pharmaceuticals, Gedeon Richter, HLL Lifecare, Cadila Healthcare, Organon and Other Prominent Players
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contraceptive market

Detailed Segmentation:

• Global Contraceptive Market, By Type
  • Combination Contraceptives
  • Monophasic pills
  • Multiphasic pills
  • Extended-cycle pills
  • Hormonal Contraceptives
  • Progestin-Only Pills
  • Emergency Contraceptives
  • Levonorgestrel-based
  • Ulipristal acetate-based
• Global Contraceptive Market, By Route of Administration
  • Oral
  • Injectable
  • Intrauterine
  • Vaginal
  • Others (Patches, etc.)
• Global Contraceptive Market, By Age Group
  • Adolescents
  • Adults
• Global Contraceptive Market, By Distribution Channel
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
• Global Contraceptive Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Top Companies in the Global Contraceptive Market:
  • Bayer AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries
  • Merck & Co.
  • Janssen Pharmaceutical Companies
  • Allergan
  • Piramal Enterprises
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mylan Pharmaceuticals
  • Mithra Pharmaceuticals
  • Gedeon Richter
  • HLL Lifecare
  • Cadila Healthcare
  • Organon
  • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Route of Administration
  • Market Snippet, By Age Group
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers:
• Increasing popularity of contraceptive drugs
• Growing government initiatives for promoting access to family planning and contraceptives
  • Restraints
• Side effects associated with pills
• Risks of blood clots and cardiovascular diseases
  • Opportunities
• Growing demand in developing countries
• Growing female population opting for contraceptive drugs
• Key Highlights
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Recent Product Approvals/Launches
• Mergers, Acquisitions, and Collaborations

4. Global Contraceptive Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Contraceptive Market, By Type, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Combination Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Monophasic pills
• Multiphasic pills
• Extended-cycle pills
• Hormonal Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Progestin-Only Pills
• Emergency Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Levonorgestrel-based
• Ulipristal acetate-based

6. Global Contraceptive Market, By Route of Administration, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Intrauterine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Vaginal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Others (Patches, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

7. Global Contraceptive Market, By Age Group, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Adolescents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

8. Global Contraceptive Market, By Distribution Channel, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

9. Global Contraceptive Market, By Region, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020 - 2031
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Company Profile
  • Bayer AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Pfizer Inc.
  • Teva Pharmaceutical Industries
  • Merck & Co.
  • Janssen Pharmaceutical Companies
  • Allergan
  • Piramal Enterprises
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mylan Pharmaceuticals
  • Mithra Pharmaceuticals
  • Gedeon Richter
  • HLL Lifecare
  • Cadila Healthcare
  • Organon
  • Other Prominent Players
• Analyst Views

11. Section

• References
• Research Methodology
• About us